Roquefort Therapeutics plc (LON:ROQ)
London · Delayed Price · Currency is GBP · Price in GBX 0.9500
-0.0500 (-5.00%)
Mar 26, 2026, 5:15 PM GMT
Roquefort Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
n/a
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 200.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 637.00 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 1.70M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Physiomics | 1.01M |
| CRISM Therapeutics | 231.00K |
| BSF Enterprise | 51.07K |
| ValiRx | 31.37K |
| Thalia Therapeutics | 7.26K |